Skip to main content

Table 1 Baseline characteristics of all patients in this study

From: Prognostic value of transthoracic echocardiography score for the prognosis of continuous ambulatory peritoneal dialysis patients

Characteristics

Survival (n = 228)

Death (n = 46)

P value

Age, years old

50.6 ± 13.1

58.0 ± 12.2

< 0.001

Gender, male, n (%)

118 (51.8)

28 (60.9)

0.333

Body mass index, kg/m2

23.1 ± 3.7

22.5 ± 2.9

0.321

Marital status, n (%)

  

0.250

Unmarried

32 (14.0)

3 (6.5)

 

Married

196 (86.0)

43 (93.5)

 

Education status, n (%)

  

0.480

Illiterate/primary

38 (16.7)

12 (26.1)

 

Middle school

87 (38.2)

17 (37.0)

 

Secondary school

62 (27.2)

10 (21.7)

 

University or above

41 (18.0)

7 (15.2)

 

Cause of ESRD, n (%)

  

0.215

Chronic glomerulonephritis

114 (50.0)

20 (43.5)

 

Diabetic nephropathy

48 (21.1)

12 (26.1)

 

Hypertensive nephropathy

39 (17.1)

12 (26.1)

 

Others or unknown

27 (11.8)

2 (4.3)

 

Comorbidities, n (%)

   

Cardiovascular disease

23 (10.1)

24 (52.2)

< 0.001

Hypertension

198 (86.6)

40 (87.0)

1.000

Diabetes

62 (27.2)

15 (32.6)

0.572

Treatments, n (%)

   

ACEI/ARB

140 (61.4)

23 (50.0)

0.203

βblockers

109 (47.8)

24 (52.2)

0.203

CCB

192 (84.2)

36 (78.3)

0.442

Diuretics

12 (5.3)

1 (2.2)

0.604

Statins/fibrates

22 (9.6)

5 (10.9)

1.000

Dialysis dose

   

Weekly total Ccr

76.8 ± 18.3

56.7 ± 16.5

0.550

Weekly renal Ccr

22.6 ± 8.3

16.6 ± 6.4

0.140

Weekly total Kt/Vurea

1.8 ± 0.5

1.7 ± 0.5

0.194

Weekly renal Kt/Vurea

0.3 ± 0.1

0.3 ± 0.2

0.424

PET at baseline

0.74 ± 0.13

0.70 ± 0.15

0.105

Laboratory results

   

White blood cells, × 109/L

7.0 ± 2.0

7.3 ± 3.3

0.293

Hemoglobin, g/L

110.0 ± 19.9

101.5 ± 22.7

0.011

Platelets, × 109/L

218.8 ± 63.6

196.2 ± 65.8

0.029

Albumin, g/L

35.4 ± 4.1

26.8 ± 3.4

0.010

Blood urea nitrogen, umol/L

19.3 ± 5.0

18.1 ± 5.1

0.134

Serum creatinine, umol/L

986.9 ± 197.5

937.5 ± 192.9

0.304

Total cholesterol, mmol/L

4.5 ± 1.0

4.4 ± 1.2

0.583

Triglyceride, mmol/L

1.9 ± 0.9

2.2 ± 1.0

0.186

HDL-C, mmol/L

1.2 ± 0.4

1.1 ± 0.3

0.120

LDL-C, mmol/L

2.2 ± 0.8

2.0 ± 0.7

0.100

Calcium, mmol/L

2.3 ± 0.2

2.4 ± 0.2

0.507

Phosphorus, mmol/L

1.7 ± 0.4

1.7 ± 0.5

0.922

iPTH, pg/mL

435.2 ± 144.5

565.5 ± 273.3

0.101

hsCRP, mg/L

6.4 ± 1.6

9.9 ± 3.7

0.043

Dialysis duration, months

29.5 (5.5, 70.0)

25.5 (2.0, 59.5)

0.659

Urine volume, mL

300.0 (0.0, 837.5)

200.0 (0.0, 750.0)

0.753

PET at baseline

0.8 ± 0.2

0.7 ± 0.2

0.364

  1. ESRD, end-stage renal disease, ACEI/ARB, angiotensin converting enzyme inhibitors/angiotensin receptor blocker, CCB, calcium calcium blockers, HDL-C, high-density lipoprotein cholesterol, LDL-C, low-density lipoprotein cholesterol, PET, peritoneal equilibration test, iPTH, intact parathyroid hormone, CRP, c-reactive protein